GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
15:47 Jul 23, 2019 |
English to French translations [PRO] Medical - Medical: Health Care / traitement du cancer | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Bertrand Leduc United Kingdom Local time: 02:24 | ||||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
4 +1 | Norme de Soin (NdS) |
|
soc Norme de Soin (NdS) Explanation: -------------------------------------------------- Note added at 6 minutes (2019-07-23 15:54:03 GMT) -------------------------------------------------- • To evaluate the effect of ADV7103 and SoC on urine pH during a long-term treatment (proportion/number of responders with urine pH values in the first morning urines and in pre-dose urines ≥ 7.0 and ≥ 7.5) • To evaluate the efficacy of ADV7103 and SoC on cystine crystalluria (including the volume of crystals of cystine - Vcys) and other other cystinuric parameters during a long-term treatment • To evaluate the efficacy of ADV7103 and SoC on other urine parameters during a longterm treatment • To evaluate the efficacy of ADV7103 and SoC on cystine calculi during a long-term treatment • To evaluate the time for any potential adding of a second line therapy with cystine chelators. • To evaluate the paraclinical and biological safety of ADV7103 and SoC during a long-term treatment. • Évaluer l'effet d’ADV7103 et de la NdS sur le pH urinaire pendant un traitement à long terme (proportion/nombre de répondeurs présentant des valeurs de pH urinaire des premières urines du matin et des urines en pré-dose ≥ 7.0 et ≥ 7.5) • Évaluer l'effet d'ADV7103 et de la NdS sur la cristallurie de la cystine (incluant le volume des cristaux de cystine - Vcys) et d'autres paramètres cystinuriques pendant un traitement à long terme. • Evaluer l'effet d'ADV7103 et de la NdS sur d'autres paramètres urinaires pendant un traitement à long terme. • Évaluer l'effet d’ADV7103 et de la NdS sur les calculs de cystine pendant un traitement à long terme. • Evaluer le temps d’ajout potentiel d’un traitement de seconde intention avec des produits chélateurs de cystine. • Evaluer la sécurité d’emploi paraclinique et biologique d'ADV7103 et de la NdS pendant un traitement à long terme. https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-... |
| |
Grading comment
| ||
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.